- Home
- MRK vs MNTSW Comparison
MRK vs MNTSW Comparison
Compare MRK & MNTSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRK | MNTSW |
|---|---|---|
| Founded | 2000 | N/A |
| Country | United States | United States |
| Employees | N/A | 123 |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.7B | N/A |
| IPO Year | 1994 | 2019 |
Fundamental Metrics
Financial Performance| Metric | MRK | MNTSW |
|---|---|---|
| Price | $120.64 | $0.01 |
| Analyst Decision | Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $123.67 | N/A |
| AVG Volume (30 Days) | ★ 6.8M | 93.6K |
| Earning Date | 04-30-2026 | N/A |
| Dividend Yield | ★ 2.83% | N/A |
| EPS Growth | ★ 8.01 | N/A |
| EPS | ★ 7.28 | N/A |
| Revenue | ★ $65,011,000,000.00 | N/A |
| Revenue This Year | $3.74 | N/A |
| Revenue Next Year | $5.47 | N/A |
| P/E Ratio | $16.52 | ★ N/A |
| Revenue Growth | ★ 1.31 | N/A |
| 52 Week Low | $75.40 | $0.01 |
| 52 Week High | $125.14 | $0.10 |
Technical Indicators
Market Signals| Indicator | MRK | MNTSW |
|---|---|---|
| Relative Strength Index (RSI) | 59.65 | 57.47 |
| Support Level | $113.27 | $0.01 |
| Resistance Level | $125.14 | $0.03 |
| Average True Range (ATR) | 2.40 | 0.00 |
| MACD | 0.45 | 0.00 |
| Stochastic Oscillator | 84.37 | 75.00 |
Price Performance
Historical ComparisonAbout MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About MNTSW Momentus Inc.
Momentus Inc offers in-space infrastructure services by building transfer and service vehicles that carry satellites and hosted payloads between orbits in space. It is a provider of three critical functions, in the new space economy: Space Transportation, Satellite as a Service, and In-Orbit Servicing.